Head and Neck Squamous Cell Carcinoma (HNSCC)Symptoms, Doctors, Treatments, Advances & More
Head and Neck Squamous Cell Carcinoma (HNSCC) Overview
Learn About Head and Neck Squamous Cell Carcinoma (HNSCC)
Otolaryngology - Head & Neck Surgery At Cherry Hill
Joseph Curry is an Otolaryngologist and a General Surgeon practicing medicine in Cherry Hill, New Jersey. Dr. Curry is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Duct Stones, Throat Cancer, Laryngectomy, and Gastrostomy. Dr. Curry is board certified in Otolaryngology. Dr. Curry is currently accepting new patients.
Jefferson Otolaryngology (ENT) - Honickman Center
Adam Luginbuhl is an Otolaryngologist practicing medicine in Philadelphia, Pennsylvania. Dr. Luginbuhl is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Laryngectomy, and Gastrostomy. Dr. Luginbuhl is board certified in Otolaryngology and Otolaryngology - Head & Neck Surgery. Dr. Luginbuhl is currently accepting new patients.
The Arthur G. James Cancer Hospital And Richard J. Solove Research Institute
Marcelo Bonomi is an Oncologist practicing medicine in Columbus, Ohio. Dr. Bonomi is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Throat Cancer, and Olfactory Neuroblastoma. Dr. Bonomi is currently accepting new patients.
Summary: Ficerafusp alfa is directed against two targets, Epidermal Growth Factor Receptor (EGFR) and Transforming Growth Factor beta (TGF-β). The study aims to demonstrate that the antitumor activity of an alternative dosing regimen of ficerafusp alfa in combination with pembrolizumab is comparable to the weekly ficerafusp alfa regimen in 1L PD-L1-positive, recurrent or metastatic Head and Neck Squamous C...
Summary: This phase II trial tests the addition of chemotherapy, with carboplatin and paclitaxel, or chemo-immunotherapy, with carboplatin, paclitaxel and cemiplimab to standard salvage surgery followed by post operative radiation therapy and cisplatin for high risk patients, for the treatment of patients with PD-L1 positive head and neck squamous cell carcinoma that has come back and spread to nearby tiss...

